Regeneron (REGN) is a publicly traded Healthcare sector company. As of July 2, 2026, REGN trades at $647.21 with a market cap of $65.37B and a P/E ratio of 14.71. REGN moved +3.08% today. Year to date, REGN is -19.53%; over the trailing twelve months it is +16.79%. Its 52-week range spans $476.49 to $834.42. Analyst consensus is buy with an average price target of $826.90. Rallies surfaces REGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Regeneron (REGN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. REGN moved +3.08% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $647.21 |
| Market Cap | $65.37B |
| P/E Ratio | 14.71 |
| EPS | $42.56 |
| Dividend Yield | 0.94% |
| 52-Week High | $834.42 |
| 52-Week Low | $476.49 |
| Volume | 167.85K |
| Avg Volume | 0 |
| Revenue (TTM) | $14.92B |
| Net Income | $4.42B |
| Gross Margin | 0.00% |
21 analysts cover REGN: 0 strong buy, 15 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $826.90.